| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652780 | The Annals of Thoracic Surgery | 2018 | 7 Pages |
Abstract
Imatinib treatment significantly improved the physiologic performance of reperfused lungs and biochemical indicators associated with reperfusion injury in this ex vivo model. Further study is necessary to elucidate the mechanism of tyrosine kinase inhibition in lungs exposed to ischemia and reperfusion.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
J. Trent MD, Joshua C. MD, Todd C. MD, Laura BA, Lakshmi PhD, R. Scott MD, Dan E. MD, Ashish S. MD, Errol L. MD, Mahendra MD, Rachel L. MD, PhD, Paul M. MD, Bo S. MD,